FDA Issues a Class I Recall of Zilver® PTX™ Drug-Eluting Peripheral Stent

Due to the seriousness of the risks involved with the use of the new Zilver® PTX™ Drug-Eluting Peripheral Stent, the FDA has issued a Class I Recall. The Zilver® PTX™ is a self-expanding stent designed to be implanted in an artery of the thigh. The outside of the device is coated with the drug Paclitaxel, […]